COMMUNIQUÉS West-GlobeNewswire

EncounterCare Solutions Inc. Announces CyberFuels New fuel shipments commence in Quebec, Canada
22/06/2018
PALM BEACH, Fla., June 22, 2018 (GLOBE NEWSWIRE) -- EncounterCare Solutions (OTC:ECSL) is pleased to announce that its Canadian distribution partner RLT Fuel Distribution Inc., Ontario, Canada has completed all the [...]
Clinical Overview of PrabotulinumtoxinA for the Investigational Treatment of Frown Lines to Be Featured During Summer Cosmetic Bootcamp 2018
22/06/2018
IRVINE, Calif., June 22, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS) (“Evolus” or the “Company”), a company dedicated to aesthetic medicine, today announced the presentation of a comprehensive overview of the [...]
Adamas Presents New Data Analysis Demonstrating that GOCOVRI™ Reduces Transitions between Dyskinesia and OFF Episodes Throughout the Day
22/06/2018
EMERYVILLE, Calif., June 22, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced the presentation of new data analysis of GOCOVRI™ (amantadine) extended release capsules, from the Phase 3 [...]
Ordinary General Meeting of Shareholders of Probiodrug AG
22/06/2018
Ordinary General Meeting of Shareholders of Probiodrug AG All proposed resolutions approved with large majority HALLE (SAALE), Germany, 22 June 2018 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage [...]
Cellular Biomedicine Group Announces Grand Opening of Global Research and Development Center in Gaithersburg, Maryland
22/06/2018
SHANGHAI, China and CUPERTINO, Calif., June 22, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc . (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of [...]
Matinas BioPharma Announces Closing of $8.0 Million Public Offering
22/06/2018
BEDMINSTER, N.J., June 22, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its [...]
Syneos Health to Share Strategies Designed to Meet the Needs of Patients, Payers and Regulators at DIA Global Annual Meeting
22/06/2018
Company to Host Annual Site Appreciation Reception to Recognize the Critical Role of Clinical Research Sites in Drug Development RALEIGH, N.C, June 22, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only [...]
Endocyte Announces Presentations on PSMA-617 at the 2018 Society of Nuclear Medicine and Molecular Imaging Annual Meeting
22/06/2018
Presentations highlight Endocyte’s alpha and beta-emitting radioligand therapies WEST LAFAYETTE, Ind., June 22, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted [...]
The American Health Council Appoints Preeti Rana, MD to Physicians Board
22/06/2018
NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- The American Health Council recently appointed Preeti Rana, MD to its Board of Physicians for her outstanding dedication to improve others’ lives at her practice, Preeti Rana [...]
Endocrinologist & Researcher Dr. Dara P. Schuster Named CEO of T1D Exchange
22/06/2018
BOSTON, June 22, 2018 (GLOBE NEWSWIRE) -- T1D Exchange , a patient-centered research organization dedicated to accelerating therapies and improving care for people with type 1 diabetes (T1D), today announced that [...]
Mustang Bio Announces Opening of CAR T Cell Therapy Manufacturing Facility in Worcester, Mass.
22/06/2018
UMass Medicine Science Park facility to support clinical development and commercialization of CAR T pipeline NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ:MBIO), a Fortress Biotech ( [...]
Pernix Therapeutics Announces Result of Bid Process for Acquisition of Worldwide Rights to Contrave® for Weight Loss
22/06/2018
MORRISTOWN, N.J., June 22, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that Nalpropion Pharmaceuticals, Inc. (“Nalpropion”), the special [...]
Coherus BioSciences Announces New Employment Inducement Grants
22/06/2018
REDWOOD CITY, Calif., June 22, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that effective June 21, 2018, the compensation committee of the company’s board of directors granted 8 new [...]
Avivagen to Exhibit Vivamune at SuperZoo
22/06/2018
OTTAWA, June 22, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]
Shire plc : Rule 2.9 Announcement
22/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 22 June 2018 Shire [...]
Shire plc: Large-Scale European Review Suggests Disparity in Symptom Recognition and Standardized Treatment for Metastatic Adenocarcinoma of the Pancreas
22/06/2018
Large-Scale European Review Suggests Disparity in Symptom Recognition and Standardized Treatment for Metastatic Adenocarcinoma of the Pancreas New analyses from the global phase III NAPOLI-1 study, also presented at the [...]
UK's MHRA renews Early Access to Medicines Scheme Scientific Opinion for Santhera's Raxone® (idebenone) in Duchenne Muscular Dystrophy
22/06/2018
Pratteln, Switzerland, June 22, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has renewed the Early Access to Medicines Scheme (EAMS) [...]
Autolus Announces Pricing of Initial Public Offering
22/06/2018
Autolus Announces Pricing of Initial Public Offering LONDON – 22 June, 2018 – Autolus Therapeutics plc (“Autolus”), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, [...]
electroCore, Inc. Announces Pricing of Initial Public Offering
22/06/2018
BASKING RIDGE, N.J., June 21, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) today announced the pricing of its initial public offering of 5,200,000 shares of common stock at a public offering price of $15. [...]

Pages